PDCD1 and malignant colon neoplasm: Recently, Zhang et al. [83] showed that TIGIT blockade appeared to reverse NK cell exhaustion, as well as enhance NK mediated anti-tumor responses in an experimental colon cancer model, both alone and in combination with anti-PD1 (programmed cell death protein 1) and anti-PD-L1 (programmed death-ligand 1).